Blog

Understanding the role of the FDA will be instrumental in my future trial work and design – Matthew Hadfield

Photo taken from AACR/X

Jul 1, 2024, 14:49

Understanding the role of the FDA will be instrumental in my future trial work and design – Matthew Hadfield

American Association for Cancer Research (AACR) shared a post on X: .

“’Understanding the role of the FDA from this fellowship will be instrumental in my future trial work and design.’

2023-24 FDA-AACR Oncology Educational Fellow – Matthew Hadfield.

Apply by August 1 to join the next class of FDA-AACR fellows.”

Source: AACR/X
.

AACR AACR Fellowship cancer Cancer Education Cancer research cancer treatment cancer trials clinical research clinical trials Educational Fellowship FDA FDA Fellowship FDA-AACR Fellowship fellowship program Matthew Hadfield medical education medical fellowship OncoDaily Oncology Oncology Education oncology fellowship research fellowship

FDA approval: Pembrolizumab for HER2 positive gastric or GEJ adenocarcinoma expressing PD-L1 (CPS ≥1): KEYNOTE-811 Trial

Changing the Future of Adolescent and Young Adult Cancer Care

OncoDaily Launches New Social Channel on Telegram – @OncoDaily

In Memory of Chadwick Boseman and His Colon Cancer Battle

Breelyn Wilky Discusses Promising Phase 1 Results of BOT/BAL in Advanced Sarcomas - Agenus